142 related articles for article (PubMed ID: 23868404)
1. Glucocorticoid receptor-dependent immunomodulatory effect of ursodeoxycholic acid on liver lymphocytes in mice.
Takigawa T; Miyazaki H; Kinoshita M; Kawarabayashi N; Nishiyama K; Hatsuse K; Ono S; Saitoh D; Seki S; Yamamoto J
Am J Physiol Gastrointest Liver Physiol; 2013 Sep; 305(6):G427-38. PubMed ID: 23868404
[TBL] [Abstract][Full Text] [Related]
2. The immunologic outcome of enhanced function of mouse liver lymphocytes and Kupffer cells by high-fat and high-cholesterol diet.
Shono S; Habu Y; Nakashima M; Sato A; Nakashima H; Miyazaki H; Kinoshita M; Tsumatori G; Shinomiya N; Seki S
Shock; 2011 Nov; 36(5):484-93. PubMed ID: 21937954
[TBL] [Abstract][Full Text] [Related]
3. Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of IFN-gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway.
Tanaka H; Makino Y; Miura T; Hirano F; Okamoto K; Komura K; Sato Y; Makino I
J Immunol; 1996 Feb; 156(4):1601-8. PubMed ID: 8568266
[TBL] [Abstract][Full Text] [Related]
4. Augmented bacterial elimination by Kupffer cells after IL-18 pretreatment via IFN-γ produced from NK cells in burn-injured mice.
Miyazaki H; Kinoshita M; Ono S; Nakashima M; Hara E; Ohno H; Seki S; Saitoh D
Burns; 2011 Nov; 37(7):1208-15. PubMed ID: 21696891
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production.
Ishizaki K; Iwaki T; Kinoshita S; Koyama M; Fukunari A; Tanaka H; Tsurufuji M; Sakata K; Maeda Y; Imada T; Chiba K
Eur J Pharmacol; 2008 Jan; 578(1):57-64. PubMed ID: 17888421
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-12 and -18 induce severe liver injury in mice recovered from peritonitis after sublethal endotoxin challenge.
Ono S; Ueno C; Seki S; Matsumoto A; Mochizuki H
Surgery; 2003 Jul; 134(1):92-100. PubMed ID: 12874588
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid suppresses eosinophilic airway inflammation by inhibiting the function of dendritic cells through the nuclear farnesoid X receptor.
Willart MA; van Nimwegen M; Grefhorst A; Hammad H; Moons L; Hoogsteden HC; Lambrecht BN; Kleinjan A
Allergy; 2012 Dec; 67(12):1501-10. PubMed ID: 23004356
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid (UDCA) suppresses liver interleukin 2 mRNA in the cholangitis model.
Miyaguchi S; Mori M
Hepatogastroenterology; 2005; 52(62):596-602. PubMed ID: 15816485
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis.
Nishikage T; Seki S; Toyabe S; Abo T; Kagata Y; Iwai T; Hiraide H
J Hepatol; 1999 Jul; 31(1):18-26. PubMed ID: 10424279
[TBL] [Abstract][Full Text] [Related]
10. Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-beta1-induced apoptosis in rat hepatocytes.
Solá S; Amaral JD; Castro RE; Ramalho RM; Borralho PM; Kren BT; Tanaka H; Steer CJ; Rodrigues CM
Hepatology; 2005 Oct; 42(4):925-34. PubMed ID: 16175607
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppression in the livers of mice with obstructive jaundice participates in their susceptibility to bacterial infection and tumor metastasis.
Kawarabayashi N; Seki S; Hatsuse K; Kinoshita M; Takigawa T; Tsujimoto H; Kawabata T; Nakashima H; Shono S; Mochizuki H
Shock; 2010 May; 33(5):500-6. PubMed ID: 19823116
[TBL] [Abstract][Full Text] [Related]
12. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
[TBL] [Abstract][Full Text] [Related]
13. Mice deficient in Vbeta8+NKT cells are resistant to experimental hepatitis but are partially susceptible to generalised Shwartzman reaction.
Habu Y; Shinomiya N; Kinoshita M; Matsumoto A; Kawabata T; Seki S
Clin Exp Med; 2007 Mar; 7(1):30-8. PubMed ID: 17380303
[TBL] [Abstract][Full Text] [Related]
14. Improved bacterial clearance and decreased mortality can be induced by LPS tolerance and is not dependent upon IFN-gamma.
Murphey ED; Fang G; Varma TK; Sherwood ER
Shock; 2007 Mar; 27(3):289-95. PubMed ID: 17304110
[TBL] [Abstract][Full Text] [Related]
15. Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells.
Arenas F; Hervias I; Uriz M; Joplin R; Prieto J; Medina JF
J Clin Invest; 2008 Feb; 118(2):695-709. PubMed ID: 18188457
[TBL] [Abstract][Full Text] [Related]
16. Kupffer cell-derived interleukin 10 is responsible for impaired bacterial clearance in bile duct-ligated mice.
Abe T; Arai T; Ogawa A; Hiromatsu T; Masuda A; Matsuguchi T; Nimura Y; Yoshikai Y
Hepatology; 2004 Aug; 40(2):414-23. PubMed ID: 15368446
[TBL] [Abstract][Full Text] [Related]
17. Novel mechanism of C-reactive protein for enhancing mouse liver innate immunity.
Inatsu A; Kinoshita M; Nakashima H; Shimizu J; Saitoh D; Tamai S; Seki S
Hepatology; 2009 Jun; 49(6):2044-54. PubMed ID: 19444871
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice.
Kato J; Okamoto T; Motoyama H; Uchiyama R; Kirchhofer D; Van Rooijen N; Enomoto H; Nishiguchi S; Kawada N; Fujimoto J; Tsutsui H
Hepatology; 2013 Jan; 57(1):362-72. PubMed ID: 22936459
[TBL] [Abstract][Full Text] [Related]
19. Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes.
Solá S; Castro RE; Kren BT; Steer CJ; Rodrigues CM
Biochemistry; 2004 Jul; 43(26):8429-38. PubMed ID: 15222754
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid induced activation of the glucocorticoid receptor in primary rat hepatocytes.
Weitzel C; Stark D; Kullmann F; Schölmerich J; Holstege A; Falk W
Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):169-77. PubMed ID: 15674094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
